Paper34813686
The role of complement in the clinical course of hepatocellular carcinoma.
Qian X and 4 others. Immun Inflamm Dis, 2022. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. The role of complement in the clinical course of hepatocellular carcinoma. Papers, record 34813686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34813686
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Biomarkers, Tumor | |
| CD8-Positive T-Lymphocytes | |
| Humans | |
| Prognosis |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28407145 | GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/28407145 | PubMed |
| 2 | 28920587 | Complement in cancer: untangling an intricate relationship. | Nat Rev Immunol | 2018 | https://conductscience.org/library/papers/28920587 | PubMed |
| 3 | 26885668 | Role of Fanconi anemia/BRCA pathway genes in hepatocellular carcinoma chemoresistance. | Hepatol Res | 2016 | https://conductscience.org/library/papers/26885668 | PubMed |
| 4 | 12414531 | Generation of C5a by phagocytic cells. | Am J Pathol | 2002 | https://conductscience.org/library/papers/12414531 | PubMed |
| 5 | 30476243 | STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30476243 | PubMed |
| 6 | 12490959 | Inflammation and cancer. | Nature | 2002 | https://conductscience.org/library/papers/12490959 | PubMed |
| 7 | 33083480 | Identification of the Sixth Complement Component as Potential Key Genes in Hepatocellular Carcinoma via Bioinformatics Analysis. | Biomed Res Int | 2020 | https://conductscience.org/library/papers/33083480 | PubMed |
| 8 | 32903581 | Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma. | Front Oncol | 2020 | https://conductscience.org/library/papers/32903581 | PubMed |
| 9 | 31709629 | CFHR3 is a potential novel biomarker for hepatocellular carcinoma. | J Cell Biochem | 2020 | https://conductscience.org/library/papers/31709629 | PubMed |
| 10 | 31441380 | C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathway. | Cancer Biol Ther | 2019 | https://conductscience.org/library/papers/31441380 | PubMed |
| 11 | 30602374 | Complement factors C3a and C5a mimick a proinflammatory microenvironment and increase HBV IGRA sensitivity. | J Transl Med | 2019 | https://conductscience.org/library/papers/30602374 | PubMed |
| 12 | 23028051 | Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression. | J Immunol | 2012 | https://conductscience.org/library/papers/23028051 | PubMed |
| 13 | 29307467 | Hepatocellular carcinoma. | Lancet | 2018 | https://conductscience.org/library/papers/29307467 | PubMed |
| 14 | 6288774 | Complement biosynthesis by the human hepatoma-derived cell line HepG2. | J Clin Invest | 1982 | https://conductscience.org/library/papers/6288774 | PubMed |
| 15 | 24613353 | Autocrine effects of tumor-derived complement. | Cell Rep | 2014 | https://conductscience.org/library/papers/24613353 | PubMed |
| 16 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 17 | 34813686 | The role of complement in the clinical course of hepatocellular carcinoma. | Immun Inflamm Dis | 2022 | https://conductscience.org/library/papers/34813686 | PubMed |
| 18 | 24367507 | Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. | PLoS One | 2013 | https://conductscience.org/library/papers/24367507 | PubMed |
| 19 | 18167066 | Liver: An organ with predominant innate immunity. | Hepatology | 2008 | https://conductscience.org/library/papers/18167066 | PubMed |
| 20 | 19293308 | Sex disparities in cancer incidence by period and age. | Cancer Epidemiol Biomarkers Prev | 2009 | https://conductscience.org/library/papers/19293308 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41909879 | Identification of STEAP4, EPC1, and CLEC1B as non-invasive candidate biomarkers for hepatocellular carcinoma using integrated bioinformatics analysis. | Biotechnol Rep (Amst) | 2026 | https://conductscience.org/library/papers/41909879 | PubMed |
| 41540504 | miR-22-Galectin-1 as an integral signaling axis in regulating metabolism and immunity in HCC. | Biomark Res | 2026 | https://conductscience.org/library/papers/41540504 | PubMed |
| 40612108 | Identification of prognostic biomarkers related to epithelial-mesenchymal transition and anoikis in hepatocellular carcinoma using transcriptomics and single-cell sequencing. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40612108 | PubMed |
| 40356904 | An immune cell activation signature reflected hepatocellular carcinoma heterogeneity and predicted clinical outcomes. | Front Immunol | 2025 | https://conductscience.org/library/papers/40356904 | PubMed |
| 40052130 | A novel nomogram based on complement C3 to predict the overall survival of early-stage hepatocellular carcinoma patients with microvascular invasion-positive undergoing curative resection. | Front Oncol | 2025 | https://conductscience.org/library/papers/40052130 | PubMed |
| 39640261 | Modulation of the hepatic RANK-RANKL-OPG axis by combined C5 and CD14 inhibition in a long-term polytrauma model. | Front Immunol | 2024 | https://conductscience.org/library/papers/39640261 | PubMed |
| 39608405 | Role of Complement in Liver Diseases. | Semin Liver Dis | 2024 | https://conductscience.org/library/papers/39608405 | PubMed |
| 39548390 | Investigating the diagnostic and prognostic significance of genes related to fatty acid metabolism in hepatocellular carcinoma. | BMC Gastroenterol | 2024 | https://conductscience.org/library/papers/39548390 | PubMed |
| 39438534 | C6 and KLRG2 are pyroptosis subtype-related prognostic biomarkers and correlated with tumor-infiltrating lymphocytes in lung adenocarcinoma. | Sci Rep | 2024 | https://conductscience.org/library/papers/39438534 | PubMed |
| 39391504 | Novel prognostic model of complement and coagulation cascade-related genes correlates with immune environment and drug sensitivity in hepatocellular carcinoma. | Heliyon | 2024 | https://conductscience.org/library/papers/39391504 | PubMed |
| 39114683 | Identification of prognostic biomarkers for hepatocellular carcinoma with vascular invasion. | Am J Transl Res | 2024 | https://conductscience.org/library/papers/39114683 | PubMed |
| 38157373 | Gene expression signatures of stepwise progression of Hepatocellular Carcinoma. | PLoS One | 2023 | https://conductscience.org/library/papers/38157373 | PubMed |
| 38090482 | Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC. | Front Oncol | 2023 | https://conductscience.org/library/papers/38090482 | PubMed |
| 37693905 | The core role of macrophages in hepatocellular carcinoma: the definition of molecular subtypes and the prognostic risk system. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37693905 | PubMed |
| 36341431 | An update on the role of complement in hepatocellular carcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/36341431 | PubMed |
| 36307751 | A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma. | BMC Cancer | 2022 | https://conductscience.org/library/papers/36307751 | PubMed |
| 34813686 | The role of complement in the clinical course of hepatocellular carcinoma. | Immun Inflamm Dis | 2022 | https://conductscience.org/library/papers/34813686 | PubMed |
Genes88
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34813686
GET https://conductscience.org/api/papers/v1/34813686/references?page=2